Human Epidermal growth factor Receptor
Full Form of HER
What is HER?
Human Epidermal growth factor Receptor (HER) refers to a family of transmembrane receptor tyrosine kinases that play a critical role in cell growth, differentiation, and survival. The HER family includes four members: HER1 (also known as EGFR), HER2, HER3, and HER4. In the Indian healthcare context, HER is most commonly associated with HER2, a protein that can promote cancer cell growth when overexpressed, particularly in breast cancer. HER2 testing is a standard diagnostic procedure in Indian oncology centres to determine eligibility for targeted therapies such as trastuzumab. The incidence of HER2-positive breast cancer in India is significant, with studies showing that about 20–30% of breast cancer patients are HER2-positive. Timely HER testing helps tailor treatment, improve outcomes, and reduce mortality. The acronym is frequently used in medical literature, pathology reports, and oncology guidelines across India. For exams like NEET PG, FMGE, and AIIMS, understanding HER receptors and their inhibitors is essential. Overall, HER remains a cornerstone of molecular oncology and personalised medicine in India.
HER का फुल फॉर्म
मानव एपिडर्मल वृद्धि कारक रिसेप्टर
Example
The oncologist recommended a HER2 test for the breast cancer patient before starting targeted therapy with trastuzumab.